Compare UFCS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFCS | INSP |
|---|---|---|
| Founded | 1946 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1995 | 2018 |
| Metric | UFCS | INSP |
|---|---|---|
| Price | $48.29 | $42.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $40.50 | ★ $94.00 |
| AVG Volume (30 Days) | 99.5K | ★ 855.5K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | 87.45 | ★ 179.43 |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $1,386,412,000.00 | $82,050,000.00 |
| Revenue This Year | $11.80 | $8.02 |
| Revenue Next Year | $8.77 | $8.11 |
| P/E Ratio | $41.68 | ★ N/A |
| Revenue Growth | 10.62 | ★ 62.18 |
| 52 Week Low | $25.81 | $38.91 |
| 52 Week High | $49.94 | $147.03 |
| Indicator | UFCS | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 46.66 |
| Support Level | $43.01 | $39.26 |
| Resistance Level | $49.94 | $44.98 |
| Average True Range (ATR) | 1.25 | 2.03 |
| MACD | 0.14 | 0.44 |
| Stochastic Oscillator | 88.29 | 65.84 |
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.